Pushing the Boundaries of Ophthalmology Innovation

Welcome to Iromed. We are a premium supplier of cutting-edge ophthalmic technologies and therapeutics.

We began our journey in 2016 as a nimble, R&D-centered startup in Italy. In fewer than 10 years, we have grown into a trailblazing international B2B player.

Today, we proudly partner with the best ophthalmology firms in the world who entrust us with the enrichment of their product portfolios.

As we look to the future, we remain fueled by our passion for life sciences and by the ambition to drive innovation in vision care.

Products

Discover our portfolio: Eye Drops, Dyes & Viscoelastics, Corneal Cross-linking, Diagnostics, Eyelids & Eye margins Care, and Dietary Supplements.

Iromed Poducts Drops Etc

ESG

We are grateful for the ecosystem that allowed us to thrive. We are motivated by a give-back spirit vis-à-vis all the communities and stakeholders that, day after day, make our journey possible.

We are in for the long run and believe strongly in inclusive, sustainable business. We are EcoVadis-certified and proud supporters of Amref Health Africa and WeCare.

Read more about our values and what we stand for here.

ESG

We are grateful for the ecosystem that allowed us to thrive. We are motivated by a give-back spirit vis-à-vis all the communities and stakeholders that, day after day, make our journey possible.

We are in for the long run and believe strongly in inclusive, sustainable business. We are EcoVadis-certified and proud supporters of Amref Health Africa and WeCare.

Read more about our values and what we stand for here.

News

Trade Fairs Season Begins!

Trade fairs season – aka the most exciting season of the year – is just around the corner.As usual, Iromed will attend ESCRS (September, Copenaghen), CPHI (October, Frankfurt), and Arab Health (Dubai, February ’26). Come visit us!

Ahead of the Curve: Iromed achieves MDR CE Approval!

Iromed Therapeutics successfully secured the MDR CE certification for multiple products, well ahead of the European deadline (December 2028).This milestone reflects our commitment to patient safety, product quality, and staying at the forefront of regulatory excellence.

Iromed Partners with Safilens to Create First Contact Lens against Digital Eye Strain

Iromed partnered with premier contact lenses manufacturer Safilens to create Delivery Ribo, a first-of-its-kind lens designed to provide protection against digital eye strain.Delivery Ribo combines the two companies’ proprietary technologies, Iromed’s first-in-class riboflavin with Safilens’ process of substance release from the contacts to the ocular surface.

Contacts & Careers

Reach out to us and we will respond promptly:

Business Development:

Customer Care:

Regulatory Affairs:

Finance:

We are always on the look for talent. If you believe in our mission, shoot an email to